The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Gene expression correlates of adagrasib response in KRASG12C mutated non-small cell lung cancer (NSCLC).
 
Eejung Kim
No Relationships to Disclose
 
Xinyuan Tong
No Relationships to Disclose
 
Ayushi Patel
No Relationships to Disclose
 
Shengwu Liu
Employment - Boston medical center (I); Theseus Pharmaceuticals
Stock and Other Ownership Interests - Theseus Pharmaceuticals
 
Julien Dilly
No Relationships to Disclose
 
Laura Hover
Employment - Treace (I)
Stock and Other Ownership Interests - Treace (I)
Patents, Royalties, Other Intellectual Property - Spine and Feet, Treace Medical Concepts, Medtronic (I)
 
Suman Mukhopadhyay
No Relationships to Disclose
 
Fiona Sherman
No Relationships to Disclose
 
James G Christensen
Employment - Mirati Therapeutics
Leadership - Mirati Therapeutics
Stock and Other Ownership Interests - Mirati Therapeutics
Consulting or Advisory Role - BridgeBio Pharma
Patents, Royalties, Other Intellectual Property - Multiple patents in last 2 years while employed at Mirati Therapeutics covering discovery of KRAS, LSD1, and EZH2 inhibitors. (Inst)
 
Peter Olson
Employment - Mirati, BMS
Leadership - Mirati, BMS
Stock and Other Ownership Interests - Mirati, Pfizer, Tango
Consulting or Advisory Role - Boxer
Research Funding - Mirati Therapeutics
Patents, Royalties, Other Intellectual Property - Mirati, UCSF
 
Andrew Aguirre
Stock and Other Ownership Interests - Kestrel Therapeutics; Riva Therapeutics
Honoraria - Phillips Gilmore Oncology
Consulting or Advisory Role - Alcon (I); Arrakis Therapeutics; AstraZeneca; Boehringer Ingelheim; Merck; Mirati Therapeutics; Nimbus Therapeutics; Plexium; Revolution Medicines; Riva Therapeutics; SERVIER; Syros Pharmaceuticals; T-Knife; Third Rock Ventures
Research Funding - Bristol-Myers Squibb/Celgene; Deerfield Management; Mirati Therapeutics; Novartis; Novo Ventures; Revolution Medicines; Syros Pharmaceuticals
 
Kwok Wong
Research Funding - Allerion Therapeutics; AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Bridgebio Pharma; Bristol-Myers Squibb; Cogent Therapeutics; Genentech; Janssen; Merus; Mirati Therapeutics; Novartis; Pfizer; Revolution Medicines; Takeda; Xilio Therapeutics; Zentalis
 
Hongbin Ji
No Relationships to Disclose